Press Releases
ATLANTA, March 13, 2023 – Renowned prostate cancer researcher Dr. Lorelei Mucci joins the American Cancer Society (ACS) as Director of Strategic Research Partnerships. In her new role, Mucci will address the alarming negative trends in prostate cancer incidence and disparities by focusing on growing and implementing a new ACS initiative called IMPACT, or “Improving Mortality Toward Prostate Cancer Together”. Mucci will also develop external collaborative partnerships and work to enhance the research funding portfolio at the ACS.
“Dr. Mucci is a great addition to the American Cancer Society’s Discovery Pillar,” said Dr. William Dahut, chief scientific officer at the American Cancer Society. “I believe she will help us grow both our research intensity and the IMPACT initiative while attracting new partners for our important work.”
While working at ACS, Dr. Mucci will remain in her current roles at Harvard T. H. Chan School of Public Health as professor of epidemiology and director of the cancer epidemiology and cancer prevention program, and deputy associate director for population science, cancer epidemiology program at the Dana-Farber/Harvard Cancer Center.
“As a cancer epidemiologist and population science researcher, I have directly observed the tremendous impact the American Cancer Society has on accelerating innovative and impactful research across the cancer continuum, and in transforming the careers of cancer researchers,” said Dr. Mucci. “I am excited to join the ACS community, to drive forward the IMPACT initiative, and to accelerate progress in reducing the burden of prostate cancer. “
Relevant to this new role, Mucci is the co-principal investigator for IRONMAN, an “International Registry to Improve Outcomes in Men with Advanced Prostate Cancer.” This global registry is enrolling men with advanced disease in 16 countries to understand the unmet needs of patients living with advanced prostate cancer, their survivorship experience, and how to better treat it. A key part of that work is focused on enhancing the geographic, racial, and socioeconomic diversity of patients enrolled in the study. She is also on the executive committees for the Transdisciplinary Prostate Cancer Partnership, the US Army Prostate Cancer Research Program Programmatic Panel, and the scientific advisory board for the Prostate Cancer Foundation.
“Given her expertise across the cancer continuum, we're delighted to have such a thoughtful leader join ACS as part of our goal to improve the lives of cancer patients and their families,” said Dr. Karen E. Knudsen, Chief Executive Officer of ACS. “Dr. Mucci embodies both scientific and leadership excellence, and we greatly look forward to working with her to accelerate our mission.”
Mucci starts in her new role at the ACS on March 13, 2023.
# # #
About the American Cancer Society
The American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 100 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. To learn more, visit cancer.org or call our 24/7 helpline at 1-800-227-2345. Connect with us on Facebook, Twitter, and Instagram.